Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest update is out from BioLargo ( (BLGO) ).
On November 14, 2025, BioLargo Inc. announced that two of its officers converted $99,901 of unpaid salary and unreimbursed business expenses into 624,383 shares of common stock at a price of $0.16 per share. These shares are subject to a Lock-Up Agreement, restricting their sale until the company achieves certain financial milestones, such as reporting gross revenue of at least $40 million, reaching a market capitalization of $300 million, or undergoing a change in control.
Spark’s Take on BLGO Stock
According to Spark, TipRanks’ AI Analyst, BLGO is a Neutral.
BioLargo’s stock score is primarily impacted by its financial performance, which shows strong revenue growth but persistent profitability and cash flow challenges. Technical analysis indicates a bearish trend, and valuation metrics are weak due to ongoing losses. Despite promising technological advancements and partnerships, financial challenges and legal disputes weigh heavily on the overall score.
To see Spark’s full report on BLGO stock, click here.
More about BioLargo
Average Trading Volume: 478,679
Technical Sentiment Signal: Sell
Current Market Cap: $48.36M
For a thorough assessment of BLGO stock, go to TipRanks’ Stock Analysis page.